banter and General Discussion, page-542

Yes but a few basics.

MSB's mesenchymal stem cells are NOT of themselves drugs. They're using natural therapies, that is, the body produces stem cells naturally.

These are safely produced in lab conditions.

And patient safety has been established already. So the risk is side effects with drugs. But this is not the issue here.

All you have is efficacy. Which has already been proven in studies and which MSB is in the process of demonstrating in clinical trials.
Plus MSB is WORLD LEADER in this field. It has led the FDA on study design and protocols.

So this risk analysis putting pharmaceutical drugs on the same risk level with MSCs, just does not compute.

It works only to lengthen the odds, I think artificially. We have to extrapolate intelligently on this and ask ourselves will the odds really be as long?

Plus this is only ONE application of MSB's MSCs. It's a lot of detail and thanks for that.

But the reader risks losing perspective on just how big MSB truly is becoming.

We have Acute Respiratory Disease Syndrome related to Covid-19, congestive heart failure, lower back pain and aGVHD. This is just looking at one, the aGVHD cancer treatment -related application.

MSB. Proving itself one step at a time.